Brief: Immutep Announces Clinical Collaboration With Msd To Evaluate Efti In Combination With Keytruda In Pivotal Phase III Trial

Immutep

03/06/2024 01:41

June 2 (Reuters) - Immutep Ltd  IMM.AX :
    * IMMUTEP ANNOUNCES CLINICAL COLLABORATION WITH MSD TO
EVALUATE
EFTI IN COMBINATION WITH KEYTRUDA® (PEMBROLIZUMAB) IN PIVOTAL
PHASE III TRIAL
    * IMMUTEP LTD - UNDER COLLABORATION, IMMUTEP WILL CONDUCT
REGISTRATIONAL TACTI-004 PHASE III TRIAL AND MSD WILL SUPPLY
KEYTRUDA

Source text for Eikon:  ID:nGNX9vfjWQ 
Further company coverage:  IMM.AX 

 ((Reuters.Briefs@thomsonreuters.com;))